Top Biotechnology Startups in 2026

Located in Toronto, Canada, Iconthin Biotech is focusing on algae-based product research and development. The two primary business lines are enterprise services and consumer-facing products development, including nutraceutical and skincare products, sunscreen and more with natural microalgae. AstaDaily® is our primary consumer-facing brand nutraceutical brand. We have two more brands coming soon for other products.

Our Company: Genista Biosciences is a rapidly growing biotech company based in San Jose, CA that is dedicated to improving public health and food safety, both on the community and global scale. Our Goal: To revolutionize food safety by creating a cutting-edge platform based on a unique combination of robotics, software, and technology. Our ability to offer fast and accurate testing while still being cost-effective allows every member of the food supply chain (big or small) to be rest assured that the food they produce is safe thereby making the world a better place.

LASE Innovation is an early-stage startup that aims to provide innovative optics solutions for broad applications. The company is currently targeting life science and diagnostic markets by commercializing LASE Particle (LP) technology initially developed at MGH, Harvard and MIT. LPs are novel laser-emitting nano/micro particles that due to their narrow emission, provide orders of magnitude more colors than conventional fluorescent probes for multiplexing and cell tracking applications. The company aims to release its first products including consumable LPs and life science instruments for single-cell analysis by the end of 2021.

At IndieBio, we are committed to building a future where biology is not only a field of study, but a technology that will help solve our world’s most challenging problems. We are part of SOSV, one of the world's top early-stage investors, and our three-month programs are designed to put founders side-by-side every day with technical experts as well as provide $500,000 in capital to ensure a fast start for world shaping ideas. Graduates of IndieBio benefit from the remarkable IndieBio community as well as well as ongoing SOSV investment through A, B and later rounds. We have locations in New York City and San Francisco. If you are driven to change the world around you, then stop waiting: APPLY NOW!

Lifebit is a leading innovator in bioinformatics software solutions and AI. In 2021, the London, UK based company closed its Series B funding round of US$60M led by Tiger Global, to fuel ongoing product innovations and global market expansion. Lifebit is pushing forward the frontiers of health and knowledge by democratising access to, and powering analyses of, omics big data. We are the pioneers revolutionising bioinformatics and biomedical data analysis. The company’s flagship product, Lifebit CloudOS, is fast becoming the industry’s standard for unified and secure research over distributed big data. On top of its core foundation, the platform provides integration to open-source analysis and visualisation tools, as well as a marketplace of proprietary ones, a powerful data and cohort browser, and advanced AI functionality that together are powering discoveries in drug discovery and vaccine development. Top tier pharmaceutical organisations, global research institutes, and bioinformatics companies the world over are deploying Lifebit CloudOS. In April 2020 we closed our Series A funding round with tremendous support from new and previous investors. Based in London, UK, Lifebit is a diverse team spanning Europe and North America, with each person empowered and involved in every aspect of the business.

Castor is a cloud-based data solution, enabling medical researchers to easily capture and integrate data from any source. Thousands of medical device, biotech and academic researchers around the world are using Castor EDC (Electronic Data Capture), eCRF, ePRO, eCOA, and eTMF to accelerate their studies. Our long-term vision reaches even further, and we are working towards a world in which: 1. Researchers can easily collaborate on similar projects 2. Diverse data sources can be linked easily, and at a small price 3. The inclusion of patients is efficient and simple, due to collaboration and smart usage of descriptive data

10x Genomics (NASDAQ: TXG) is one of the fastest growing biotech companies, growing from $3M in revenue in 2015 to $240M in 2019. We create hardware, chemistry, and software that accelerates biological research. Our products are used by scientists around the world, including 96 of the top 100 global research institutions. Our mission is to build products that will be used throughout the rest of this century, to better understand, and eventually conquer disease. Behind every breakthrough is an extensive network of talented individuals contributing their unique perspectives, backgrounds, and areas of expertise. This kind of collaboration is essential to building a strong and effective workplace, and it’s our goal to create an inclusive environment that reflects the diversity of the communities and the goals that we serve. The discoveries we make now, as a team, will lead to better technologies, better treatments, and a better future.

Our mission is to harness advanced technologies to increase our understanding of the biology that underlies lifespan, and to seek interventions that enable people to lead longer and healthier lives. We bring together scientists and technologists, thinkers and tinkerers, to explore the fundamental biology of aging. At Calico, you'll work closely with scientists to help ask big scientific questions, and invent software to help answer them. We're part of the Alphabet family, which includes Google, Verily, Waymo, and other companies.

Ark is building the world’s highest-fidelity bioprocess simulation software to help life-saving therapies reach patients faster. By democratizing complex AI x multi-physics models in an intuitive software interface, we are transforming how bioprocess scientists work.